Moreover, TTR is an interesting therapeutic target for neurodegenerative diseases due to its recognized neuroprotective properties in the cognitive impairment context and interestingly in Alzheimer’s disease (AD). The gene discussed is TTR; the disease is early-onset autosomal dominant Alzheimer disease.